^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Rhabdomyosarcoma
    Drug:methotrexate (THF dehydrogenase inhibitor, Dihydrofolic acid reductase inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Rhabdomyosarcoma: Other Recommended Regimens…Methotrexate